Our VAP© technology has been chosen for the analysis of more than 65,000 clinical research specimens from a variety of studies, including those listed here:

• KALETRA Study
• Active Study
• Avandia Study
• BARC Study
• Emory Estrogen Vascular Study
• FORCE Trial
• Framingham Study
• FROST Study
• HATS Trial
• Johns Hopkins Sibling Study
• SHEAR Study
• Merck Safari and Silhouette Studies
• Early Trial
• Fibercel Pilot Trial
• NIA-NIH Vascular Aging Study
• Native American CHD Risk Factor Study
• AstraZeneca Rosuvastatin Study
• Pfizer-Lipitor Study
• Triumph Trial
• UPMC Heart SCORE Study
• Vanderbilt Pediatric Cardiovascular Morbidity Study
• RACED Study
• WAVE Trial
• Yale Pathophysiology of Type 2 Diabetes in Youth Study

“I found Atherotech to be an important asset to my research study. The company is highly professional and provided my on-line results in a timely and organized fashion.”

-Bonnie Marblestone, RN, CFNP, PhD-c,
Primary Investigator
University of San Diego School of Nursing